FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and chemical-pharmaceutical industry, namely to drug preparations used in various spastic intestinal and pancreatic-biliary conditions, especially in irritable bowel syndrome, and to methods for making them. The drug preparation in the form of an orally dispersible tablet characterised by the fact that it contains a combination of hyoscine butyl bromide and diclofenac or its sodium salt in complex with polacrilin potassium in ratio of diclofenac or its sodium salt and polacrilin potassium of 1:2, and pharmaceutically acceptable additives containing mannitol, aspartame and crospovidone. Polyvinyl pyrrolidone K30, a flavouring agent and anhydrous colloidal silicon dioxide.
EFFECT: tablets have the improved bioavailability of the agent.
2 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW THERAPEUTIC COMPOSITION FOR TREATING PAIN SYNDROME ACCOMPANYING SMOOTH MUSCLE SPASM | 2012 |
|
RU2497505C1 |
| ORALLY DISINTEGRATING TABLET OF DEHYDROEPIANDROSTERONE AND/OR COMBINATION OF DEHYDROEPIANDROSTERONE AND L-THEANINE | 2014 |
|
RU2557960C1 |
| ORALLY DISPERSIBLE TABLET OF DEHYDROEPIANDROSTERONE | 2014 |
|
RU2545812C1 |
| NADH COMPOSITION HAVING ANTIOXIDANT PROPERTIES | 2014 |
|
RU2545920C1 |
| COMBINATION IN ORAL DISPERSIBLE FORM WITH THERAPEUTIC ACTION ON ACTIVATING AND INHIBITORY FUNCTIONS OF NERVOUS SYSTEM (VERSIONS) | 2011 |
|
RU2464013C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING MENTAL, BEHAVIOUR AND COGNITIVE DISORDERS | 2012 |
|
RU2488388C1 |
| DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
| COMBINATION OF MIRTAZAPINE AND TIZANIDINE FOR USE IN PAIN DISORDERS | 2019 |
|
RU2736713C1 |
| SOLID ENTERIC ORAL DOSAGE FORM OF PROINSULIN C-PEPTIDE (VERSIONS) AND METHOD FOR PREPARING IT (VERSIONS) | 2013 |
|
RU2522897C1 |
| ANTIVIRAL AND IMMUNOSTIMULATING DRUG | 2015 |
|
RU2593570C1 |
